San Francisco, CA, United States of America

Ian Driver

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Inventor Profile: Ian Driver from San Francisco, CA**

Introduction

Ian Driver is a distinguished inventor based in San Francisco, California. Known for his innovative contributions to the field of biotechnology, he has developed groundbreaking patents that have the potential to advance medical treatments significantly.

Latest Patents

Ian Driver holds a notable patent for "Anti-human TREM2 antibodies and uses thereof." This invention pertains to antigen binding proteins, specifically monoclonal antibodies that are designed to bind to and activate human triggering receptor expressed on myeloid cells-2 (TREM2). The patent outlines pharmaceutical compositions that include these antigen binding proteins, which are capable of activating TREM2/DAP12 signaling in myeloid cells without the need for Fc-mediated cross-linking. The methods associated with Driver's invention aim to treat or prevent conditions linked to TREM2 loss of function, such as Alzheimer's disease and multiple sclerosis.

Career Highlights

Ian Driver is currently employed at Amgen Inc., a leading biotechnology company. His work there focuses on developing innovative therapeutic solutions that harness the power of monoclonal antibodies due to their specificity and efficacy in treating various diseases. His dedication and expertise in his field have led to significant advancements in the understanding and treatment of neurodegenerative conditions.

Collaborations

Throughout his career, Ian Driver has collaborated with esteemed colleagues, including Ian Nevin Foltz and Shilpa Sambashivan. These partnerships have fostered a creative environment that encourages innovative thinking and research, enabling the development of novel therapeutic strategies.

Conclusion

Ian Driver exemplifies the spirit of innovation in biotechnology through his patent for anti-human TREM2 antibodies. His work at Amgen Inc. and collaborations with fellow researchers continue to push the boundaries of medical science, providing hope for improved treatments for significant health conditions. With his contributions, Driver is making a lasting impact in the field of healthcare and therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…